Pharmaceutical methods having dopaminergic activity

Details Pharmaceutical methods having dopaminergic activity Pharmaceutical methods having dopaminergic activity

1986-04-02

1987-06-16

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3144

Patent

active

046736816

ABSTRACT:
A pharmaceutical composition containing .alpha.-dihydroergocryptine, or a salt thereof, is used in combination with pharmaceutically acceptable carrier means or excipient for the treatment of Parkinson's disease, depression or cephalalgias is disclosed. A method for administering the composition to a patient is also provided.

REFERENCES:
A Rating Scale for Depression by: Max Hamilton.
The Evaluation of Extrapyramidal Disease by: Roger C. Duvoisin.
A Comparative, Multicenter Trial between Bromocriptine and Amitriptyline in the Treatment of Endigenous Depression.
The Lancet, vol. 1, p. 735, Apr. 8, 1978.
Physician's Desk Reference 1982, p. 1684-Sandoz-Cont.
Critical Analysis of the Disability in Parkinson's Disease by: David D. Webster, MD.
Chem. Abst. (1969)-71 42281p.

Affiliated with

Also associated with

Rating

Pharmaceutical methods having dopaminergic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical methods having dopaminergic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical methods having dopaminergic activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-684050